Exome Asset Management’s Lexeo Therapeutics LXEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-88,148
Closed -$797K 72
2024
Q3
$797K Buy
+88,148
New +$797K 0.54% 51